168 related articles for article (PubMed ID: 34503086)
1.
Kuang X; McAndrew MJ; Mustachio LM; Chen YC; Atanassov BS; Lin K; Lu Y; Shen J; Salinger A; Macatee T; Dent SYR; Koutelou E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503086
[No Abstract] [Full Text] [Related]
2. Ubiquitin-specific peptide 22 acts as an oncogene in gastric cancer in a son of sevenless 1-dependent manner.
Lim C; Xu JC; Chen TY; Xu JX; Chen WF; Hu JW; Li QL; Zhang YQ
Cancer Cell Int; 2020; 20():45. PubMed ID: 32063746
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
[TBL] [Abstract][Full Text] [Related]
4. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
Gennaro VJ; Stanek TJ; Peck AR; Sun Y; Wang F; Qie S; Knudsen KE; Rui H; Butt T; Diehl JA; McMahon SB
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9298-E9307. PubMed ID: 30224477
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer.
Jeusset LM; McManus KJ
Cancers (Basel); 2017 Dec; 9(12):. PubMed ID: 29210986
[TBL] [Abstract][Full Text] [Related]
6. USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta.
Koutelou E; Wang L; Schibler AC; Chao HP; Kuang X; Lin K; Lu Y; Shen J; Jeter CR; Salinger A; Wilson M; Chen YC; Atanassov BS; Tang DG; Dent SYR
Development; 2019 Feb; 146(4):. PubMed ID: 30718289
[TBL] [Abstract][Full Text] [Related]
7. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
[TBL] [Abstract][Full Text] [Related]
8. Histone H2Bub1 deubiquitylation is essential for mouse development, but does not regulate global RNA polymerase II transcription.
Wang F; El-Saafin F; Ye T; Stierle M; Negroni L; Durik M; Fischer V; Devys D; Vincent SD; Tora L
Cell Death Differ; 2021 Aug; 28(8):2385-2403. PubMed ID: 33731875
[TBL] [Abstract][Full Text] [Related]
9. RNF220 promotes gastric cancer growth and stemness via modulating the USP22/wnt/β-catenin pathway.
Deng T; Zhong P; Lou R; Yang X
Tissue Cell; 2023 Aug; 83():102123. PubMed ID: 37295272
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
11. The SAGA complex regulates early steps in transcription via its deubiquitylase module subunit USP22.
Stanek TJ; Gennaro VJ; Tracewell MA; Di Marcantonio D; Pauley KL; Butt S; McNair C; Wang F; Kossenkov AV; Knudsen KE; Butt T; Sykes SM; McMahon SB
EMBO J; 2021 Aug; 40(16):e102509. PubMed ID: 34155658
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway.
Li Z; Huang X; Hu W; Lu H
Tissue Cell; 2022 Aug; 77():101787. PubMed ID: 35623308
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Merino VF; Cho S; Liang X; Park S; Jin K; Chen Q; Pan D; Zahnow CA; Rein AR; Sukumar S
Mol Oncol; 2017 May; 11(5):552-566. PubMed ID: 28296140
[TBL] [Abstract][Full Text] [Related]
14. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
15. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
[TBL] [Abstract][Full Text] [Related]
16. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract][Full Text] [Related]
17. Usp22 deficiency impairs intestinal epithelial lineage specification in vivo.
Kosinsky RL; Wegwitz F; Hellbach N; Dobbelstein M; Mansouri A; Vogel T; Begus-Nahrmann Y; Johnsen SA
Oncotarget; 2015 Nov; 6(35):37906-18. PubMed ID: 26431380
[TBL] [Abstract][Full Text] [Related]
18. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.
Schrecengost RS; Dean JL; Goodwin JF; Schiewer MJ; Urban MW; Stanek TJ; Sussman RT; Hicks JL; Birbe RC; Draganova-Tacheva RA; Visakorpi T; DeMarzo AM; McMahon SB; Knudsen KE
Cancer Res; 2014 Jan; 74(1):272-86. PubMed ID: 24197134
[TBL] [Abstract][Full Text] [Related]
19. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
20. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
